Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Q/C TECHNOLOGIES, INC. Director's Dealing 2015

Dec 14, 2015

35313_dirs_2015-12-14_a6acee6e-1752-4c26-8fd1-634d5bb30806.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Akers Biosciences Inc (AKER)
CIK: 0001321834
Period of Report: 2015-11-11

Reporting Person: Bokhari Raza (Director)